The ROE as of December 2024 (TTM) for Protara Therapeutics, Inc. (TARA) is -55.96%

According to Protara Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -55.96%. This represents a change of 285.87% compared to the average of -14.50% of the last 4 quarters.

Protara Therapeutics, Inc. (TARA) Historical ROE (quarterly & annually)

How has TARA ROE performed in the past?

The mean historical ROE of Protara Therapeutics, Inc. over the last ten years is -72.17%. The current -55.96% ROE has changed -22.46% with respect to the historical average. Over the past ten years (40 quarters), TARA's ROE was at its highest in in the December 2019 quarter at 40.44%. The ROE was at its lowest in in the December 2022 quarter at -38.07%.

Protara Therapeutics, Inc. (TARA) ROE by Quarter and Year

Discovering the peaks and valleys of Protara Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Protara Therapeutics, Inc. (TARA) Average ROE

How has TARA ROE performed in the past?

The current ROE of Protara Therapeutics, Inc. (TARA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Protara Therapeutics, Inc. (TARA) ROE vs. Peers

How is TARA’s ROE compared to its peers?

Protara Therapeutics, Inc.’s ROE is less than Vaccinex, Inc. (1.93%), greater than Monopar Therapeutics Inc. (-21731.73%), greater than Miromatrix Medical Inc. (-70.01%), greater than Surrozen, Inc. (-222.75%), less than Ikena Oncology, Inc. (0%), greater than Xilio Therapeutics, Inc. (-39.59%), greater than Scholar Rock Holding Corporation (-214.74%), greater than Vaccitech plc (-145.60%), greater than Metacrine, Inc. (-34.39%), greater than Magenta Therapeutics, Inc. (-83.52%), greater than TRACON Pharmaceuticals, Inc. (-14.27%), greater than Satsuma Pharmaceuticals, Inc. (-237.65%), less than Lyra Therapeutics, Inc. (125.24%), greater than Trevi Therapeutics, Inc. (-178.68%), greater than SQZ Biotechnologies Company (-63.30%), greater than null (-305.92%),

Build a custom stock screener for Protara Therapeutics, Inc. (TARA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Protara Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Protara Therapeutics, Inc. (TARA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Protara Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.